Approval · Notice of Compliance 1283 · 2000
NOZINAN: Notice of Compliance 1283
Issued November 14, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1283
- Date
- November 14, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Neuroleptic
Products in this notice
Medicinal ingredients
- METHOTRIMEPRAZINE MALEATE 2 MG per TAB
- METHOTRIMEPRAZINE MALEATE 5 MG per TAB
- METHOTRIMEPRAZINE MALEATE 25 MG per TAB
- METHOTRIMEPRAZINE MALEATE 50 MG per TAB
- METHOTRIMEPRAZINE HCL 40 MG per ML
- METHOTRIMEPRAZINE HCL 5 MG per ML
- METHOTRIMEPRAZINE HCL 25 MG per ML